Literature DB >> 7586148

p53 expression in normal versus transformed mammalian cells.

F Moro1, L Ottaggio, S Bonatti, M Simili, M Miele, S Bozzo, A Abbondandolo.   

Abstract

To answer the question whether the level of p53 expression also reflects the status of a cell, with reference to transformation and genome stability, we have examined, by immunocytochemistry, the presence of p53 protein in a number of cell types including human diploid cells, Chinese hamster embryonal cells at different passages and gene amplified and/or transformed Chinese hamster cell lines. Primary human fibroblasts at early passage (LEO) and an established, non transformed, Chinese hamster cell line at early passage (CHEF/18) did not show any detectable p53 expression, either nuclear or cytoplasmic. All transformed human (Raji) and Chinese hamster cell lines (CHO, V79, V79/B7) showed a nuclear expression of p53, although at different intensities. Two cell lines selected from V79/B7 for their resistance to phosphonacetyl-L-aspartate or methotrexate and previously shown to bear gene amplification, showed p53 expression. In PALA L cells p53 expression was nuclear as in other positive cell lines tested, while in MTX M cells it was cytoplasmic. CHEF/18 cells at late passage in culture showed the typical behaviour of transformed cells and p53 was detected in several cells. Moreover, when transformed CHO cells were treated with compounds known to induce reverse transformation, both the disappearance of hallmarks of transformed phenotype and p53 reduction were observed. These results indicate a strong association within the same cell type between p53 expression and transformed status.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586148     DOI: 10.1093/carcin/16.10.2435

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Deciphering phenotypic variance in different models of DNA-PKcs deficiency.

Authors:  Jessica A Neal; Katheryn Meek
Journal:  DNA Repair (Amst)       Date:  2018-10-30

2.  The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair.

Authors:  W Chaung; L J Mi; R J Boorstein
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

3.  Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells.

Authors:  Nicole G Coufal; Josè Luis Garcia-Perez; Grace E Peng; Maria C N Marchetto; Alysson R Muotri; Yangling Mu; Christian T Carson; Angela Macia; John V Moran; Fred H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-09       Impact factor: 11.205

4.  Microtubule-interacting drugs induce moderate and reversible damage to human bone marrow mesenchymal stem cells.

Authors:  H Polioudaki; M-C Kastrinaki; H A Papadaki; P A Theodoropoulos
Journal:  Cell Prolif       Date:  2009-05-22       Impact factor: 6.831

5.  Nuclear Tau, p53 and Pin1 Regulate PARN-Mediated Deadenylation and Gene Expression.

Authors:  Jorge Baquero; Sophia Varriano; Martha Ordonez; Pawel Kuczaj; Michael R Murphy; Gamage Aruggoda; Devon Lundine; Viktoriya Morozova; Ali Elhadi Makki; Alejandra Del C Alonso; Frida E Kleiman
Journal:  Front Mol Neurosci       Date:  2019-10-15       Impact factor: 5.639

6.  Urodele p53 tolerates amino acid changes found in p53 variants linked to human cancer.

Authors:  Eric Villiard; Henner Brinkmann; Olga Moiseeva; Frédérick A Mallette; Gerardo Ferbeyre; Stéphane Roy
Journal:  BMC Evol Biol       Date:  2007-09-28       Impact factor: 3.260

7.  p53 Is Active in Human Amniotic Fluid Stem Cells.

Authors:  Melissa Rodrigues; Ivana Antonucci; Seham Elabd; Shilpa Kancherla; Marco Marchisio; Christine Blattner; Liborio Stuppia
Journal:  Stem Cells Dev       Date:  2018-10-02       Impact factor: 3.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.